Max Zusman

978 citations
27 papers · 721 indexed · h-index 14
Topics
Musculoskeletal pain and rehabilitation (23 papers)Pain Mechanisms and Treatments (12 papers)Pain Management and Placebo Effect (10 papers)

In The Last Decade

Max Zusman

27 papers receiving 635 citations

Peers

Max Zusman
Comparison fields: 5 of 77
  • Pharmacology 507
  • Physiology 169
  • Cell Biology 155
  • Psychiatry and Mental health 148
  • Surgery 147
Replace Carolina Valencia with:
Carolina Valencia United States
John Booth Australia
Sarah Eberhart United States
Sirkka‐Liisa Karppi Finland
John Srbely Canada
Megan Donaldson United States
Matti Nykänen Finland
Ashley Pedler Australia
Martin Rabey Australia
Paul van Wilgen Belgium
Max Zusman relative to Carolina Valencia United States Carolina Valencia's profile →
Citations per field
00.5×1.5×
Carolina Valencia · 1×
Citations per year

Countries citing papers authored by Max Zusman

Since Specialization
Citations

This map shows the geographic impact of Max Zusman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Zusman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Zusman more than expected).

Fields of papers citing papers by Max Zusman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Zusman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Zusman. The network helps show where Max Zusman may publish in the future.

Co-authorship network of co-authors of Max Zusman

This figure shows the co-authorship network connecting the top 25 collaborators of Max Zusman. A scholar is included among the top collaborators of Max Zusman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Zusman. Max Zusman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 28
2 2
3 8
4 6
5 12
6 5
7 17
8 1
9 12
10 125
11 74
12 48
13 65
14 16
15 7
16 23
17 28
18 50
19 36
20 7

About Max Zusman

Max Zusman is a scholar working on Pharmacology, Cell Biology and Psychiatry and Mental health, having authored 27 papers that have together received 721 indexed citations. Recurring topics across this work include Musculoskeletal pain and rehabilitation (23 papers), Pain Mechanisms and Treatments (12 papers) and Pain Management and Placebo Effect (10 papers). The work is most often cited by research in Pharmacology (507 citations), Orthopedics and Sports Medicine (90 citations) and Psychiatry and Mental health (148 citations). Max Zusman has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Toby Hall, Anthony G. Schneiders, Kevin P. Singer, John Quintner, Robert Elvey, Garry T. Allison, Lance Twomey, Neil J. McLean and Peter O’Sullivan. Their work appears in journals such as The Medical Journal of Australia, European Journal of Pain and Medical Hypotheses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026